Allergy/Asthma News

New data from the phase 3 TYREE study demonstrate efficacy of a fixed-dose combination of budesonide and albuterol in a single pressurized metered-dose inhaler to prevent exercise-induced bronchoconstriction in individuals with asthma.

A 200 mg single-dose prefilled pen for Dupixent has been approved by the FDA for at-home use to treat certain patients with atopic dermatitis, asthma and chronic rhinosinusitis with nasal polyposis, according to a company announcement.

Transition to a high-deductible health plan that largely exempted medications from the deductible was associated with minimal or no change in use of asthma controllers and exacerbations among children and adults with persistent asthma.

Self-monitoring using a digital platform and remote clinician feedback helped patients maintain adherence to inhaled corticosteroids and decreased short-acting beta agonist use, researchers reported.

Tezepelumab reduced asthma exacerbations requiring hospitalization or ED visits in adults and adolescents with severe, uncontrolled asthma, according to new data from the NAVIGATOR trial.

Adults with asthma living in neighborhoods that were deprioritized for mortgage investments in the 1930s, or redlined, had worse lung function than those living in non-redlined areas, researchers reported.

In this video, Leonard B. Bacharier, MD, presents results of the LIBERTY ASTHMA VOYAGE trial, which evaluated dupilumab in children aged 6 to 11 years with uncontrolled moderate to severe asthma with evidence of type 2 inflammation.

Thirty-five percent of adults in the United States who were surveyed said they would consider leaving their primary care physician for qualified physicians providing on-demand telehealth services.

Triple therapy, compared with dual therapy, was associated with fewer asthma exacerbations and modest improvements in asthma control in children and adults with moderate to severe asthma, according to a new meta-analysis.

Researchers said they have found evidence that children exposed to ultrafine particles from air pollution in utero were more likely to develop asthma than unexposed children.